ImpriMed

ImpriMed is a precision medicine company. From its funding announcement.

$10M BridgeRaised 3 days agoSeoul, USAOtherUSA
Visit website →

In their own words

What ImpriMed says it is doing

Work here? Claim your company profile

Public signal Described in the funding announcement as "precision medicine company". Source

Market expansionCommercial growthAsia expansion

Public signal Read from the company's own description of what the funding supports.

Why now

Where ImpriMed is today

ImpriMed announced a funding round of $10M on 21 September 2026, led by LB Investment.

Latest round
Bridge
Amount
$10M
Announced
21 September 2026
Headquarters
Seoul, USA
Sector
Other
Growth stage
Growth
Investors
Also participating
NAVER D2SF, Samsung Securities, Alois Ventures, BonAngels, Han River Partners
Relevant leadership
Not stated

Momentum AfterRaise intelligence

AfterRaise Score

60
Steady growth
1 funding signal in the last 90 days
Funding recency
40/40
announced within the last 30 days
Round scale
12/25
round size relative to the market
Funding stage
8/20
Bridge
Funding cadence
0/15
one funding event tracked this year
Arriving with the signals layer
  • Hiring momentum Open roles and hiring pace
  • Market expansion New offices and new countries
  • Leadership Executive appointments
  • Product activity Launches and releases

Since the raise

What has happened since

  • 21 September 2026
    $10M Bridge
    Led by LB Investment.

Public signal The timeline currently holds funding events, because those are the signals AfterRaise observes today. Hiring, leadership, expansion and product events join it with the signals layer.

What may happen next

What this raise could create

AfterRaise intelligenceNot a statement of fact

What may happen next

  • Asia market entry
  • New market entry
  • First local hires in the new market
  • Local entity and legal setup

Opportunities this could create

  • Commercial leadership
  • Operations hiring
  • Go-to-market partnerships
  • Market-entry advisers
  • Local employment infrastructure

Based on the Other sector, a Growth round and the priorities the company itself set out. Not a statement of fact.

High momentum4 connected signals
  • 21 September 2026$10M Bridge announced
  • 21 September 2026Stated priority: market expansion
  • 21 September 2026Stated priority: commercial growth
  • 21 September 2026Stated intent: asia expansion AfterRaise intelligence

High momentum means several meaningful company changes have occurred in a short period. Signals here are funding events and the priorities the company stated; hiring, leadership and expansion detection join with the signals layer.

Open to

What ImpriMed is open to

Not yet specified

ImpriMed has not told AfterRaise which approaches it welcomes. Until it does, we do not assume. Offers to help are held and shown to the company, and the company decides whether to open a conversation.

Work here? Set your preferences

Opportunities

Ways to work with ImpriMed

No open opportunities listed

Jobs, projects, partnerships, advisory and supplier needs appear here once the company has claimed its page and published them, and any role we read from its own job board appears automatically.

Work here? Open the first one

Helpful contributors

People who have contributed here

Nobody yet

When someone offers help and the company says it was useful, they appear here. Reputation on AfterRaise is built from contributions the company confirmed, not from follower counts.

Do you work at ImpriMed?

Claim your company profile.

This page was created from publicly available information. A verified representative corrects the record, says what the company is building next and chooses which conversations it welcomes.

What we do not have yet: the roles and projects you have open and who leads the team. Claiming the page is how you fill those in.

Someone else requesting access does not give them ownership. Every representative is verified by a person before access is granted.

Maintaining your own company profile is free. A founder, CEO or authorised senior colleague can represent the company.

Also moving

Other Other companies

See the sector